发明名称 |
METHODS FOR TREATMENT OF PRIMARY CANCER AND CANCER METASTASIS |
摘要 |
<p>Embodiments of the invention are directed to administering a therapeutically effective amount of a purinergic P2 receptor agonist alone or in combination with adenosine receptor antagonist and/or other anti-cancer therapies for the treatment of cancer. Agonist for the P2 receptors include non-hydrolysable ATP analogs. In particular aspects the cancer is a metastatic cancer, such as a bone metastasis.</p> |
申请公布号 |
WO2014074529(A1) |
申请公布日期 |
2014.05.15 |
申请号 |
WO2013US68610 |
申请日期 |
2013.11.06 |
申请人 |
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
发明人 |
JIANG, JEAN, X.;ZHOU, JADE, ZIFEI |
分类号 |
A61K31/7076;A61K31/522;A61K35/00 |
主分类号 |
A61K31/7076 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|